v3.26.1
SCHEDULE OF COMMON STOCK OUTSTANDING (Details) - Common Stock [Member] - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of Options Outstanding and Vested, Outstanding, Balance 40,667 50,667  
Weighted Average Exercise Price, Outstanding, Balance $ 0.2041 $ 15.9474  
Remaining Contractual Life (Years) 4 years 1 month 6 days 3 years 5 months 8 days 2 years 4 months 24 days
Aggregated Intrinsic Value, Balance $ 249,122 $ 776,864  
Number of Options Outstanding and Vested, Issued 439,996 [1] 429,996 [2]  
Weighted Average Exercise Price, Issued $ 0.0077 [1] $ 0.0077 [2]  
Number of options outstanding and vested, exercised (409,996) [3] (399,996) [4]  
Weighted average exercise price, exercised $ 0.0075 [3] $ 0.0075 [4]  
Number of options outstanding and vested, expired  
Weighted average exercise price, expired  
Number of options outstanding and vested, forfeited  
Weighted average exercise price, forfeited  
Number of options outstanding and vested, cancelled (40,000)  
Weighted average exercise price, cancelled $ 20.0000  
Number of Options Outstanding and Vested, Outstanding, Balance 70,667 40,667 50,667
Weighted average exercise price, outstanding ending $ 0.1217 $ 0.2041 $ 15.9474
Aggregated Intrinsic Value, Balance $ 290,321 $ 249,122 $ 776,864
[1] In the year ended December 31, 2025, 439,996 common stock options were issued with a grant date fair value of $ 3,066,772.
[2] In the year ended December 31, 2024, 429,996 common stock options were issued with a grant date fair value of $13,410,147.
[3] In the year ended December 31, 2025, common stock option holders exercised a total 409,996 options at a weighted average exercise price of $0,0075 to purchase our common stock. The exercises were paid for with $3,116 in cash proceeds to us. As a result of the options exercised, we issued 409,996 shares of common stock.
[4] In the year ended December 31, 2024, common stock option holders exercised a total 399,996 options at a weighted average exercise price of $0,0075 to purchase 399,996 shares of our common stock. The exercises were paid for with $2,999 in cash proceeds to us. As a result of the options exercised, we issued 399,996 shares of common stock.